Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...
Weight loss drugs like Ozempic deliver more health benefits than expected.
Chronic Kidney Disease is a silent killer that progresses gradually, often going unnoticed until the late stages. While ...
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.